Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Giovanella L, Suriano S, Ricci R, Ceriani L, Anton Verburg F (2011) Postsurgical thyroid remnant estimation by 99mTc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroidcarcinoma. Head Neck 33:552–556.
https://doi.org/10.1002/hed.21490
2. Silva F, Martin RJ, Figueroa J, Rincón F, Román D (2016) Variability of serum thyroglobulin levels in post- thyroidectomy patients with well-differentiated thyroid cancer: the ATA guidelines. P R Health Sci J 35:142–146
3. Liu G, Li N, Li X, Chen S, Du B, Li Y (2016) Thyroid remnant estimation by diagnostic dose 131I scintigraphy or 99mTcO4− scintigraphy after thyroidectomy: a comparison with therapeutic dose 131I imaging. Biomed Res Int 2016:4763824.
https://doi.org/10.1155/2016/4763824
4. Bai JB, Shakerian R, Westcott JD, Lichtenstein M, Miller JA (2015) Factors influencing radioiodine uptake after thyroid cancer surgery. ANZ J Surg 85:572–577.
https://doi.org/10.1111/ans.12368
5. Yap BK, Homer J, Parrott N, Loughran S, Murby B, Swindell R, Gandhi A (2013) Use of pre-ablation radioiodine-131 scan to assess the impact of surgical volume and specialisation following thyroidectomy for differentiated thyroid carcinoma. Eur Thyroid J 2:275–281.
https://doi.org/10.1159/000355911